Is there any role for sentinel node mapping in colorectal cancer staging? Personal experience and review of the literature

Japanese Journal of Clinical Oncology

Volumn 35, Issue 11, 2005, Pages 645-650

  Codignola, Claudio ^a   Zorzi, F ^a   Zaniboni, A ^a   Mutti, S ^a   Rizzi, A ^a   Padolecchia, E ^a   Morandi, G B ^a  

^a Department of General Surgery ^*  (Italy)

Author keywords

Colonic neoplasms; Colorectal carcinoma; Colorectal surgery; Lymphatic metastasis; Sentinel lymph node biopsy

Indexed keywords

DISULFINE BLUE;

ADULT; AGED; CANCER STAGING; COLORECTAL CANCER; COLORECTAL SURGERY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; REVIEW; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE MAPPING; TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 30444446944     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyi182     Document Type: Review

References (49)

1. Andre T, de Gramont A, Study Group of Clinical Research in Radiotherapies Oncology, Oncology Multidisciplinary Research Group. An overview of adjuvant systemic chemotherapy for colon cancer. Clin Colorectal Cancer 2004;4(Suppl 1):S22-8.
2. Zaniboni A, Labianca R, Gruppo Italiano per to Studio e la Cura dei Tumori del Digerente. Adjuvant therapy for stage II colon cancer: An elephant in the living room? Ann Oncol 2004;15:1310-8.
3. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456-66.
4. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220: 391-8.
5. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
6. Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H. Can sentinel node biopsy indicate rational extent of lymphadenectomy in gastric cancer surgery? Fundamental and new information on lymph node dissection. Langenbecks Arch Surg 1999;384:149-57.
7. Saha S, Ganatra BK, Gauthier J. Localization of sentinel lymph node (SLN) in colon cancer (CrCa). A feasibility study. Society of Surgical Oncology Symposium Abstract Book 1997;54 (Abstr 80).
8. Bilchik AJ, Saha S, Wiese D, Stonecypher JA, Wood TF, Sostrin S, et al. Molecular staging of early colon cancer on the basis of sentinel node analysis: A multicenter phase II trial. J Clin Oncol 2001;19:1128-36.
9. Wood TF, Spirt M, Rangel D, Shen P, Tsioulias GJ, Morton DL, et al. Lymphatic mapping improves staging during laparoscopic colectomy for cancer. Surg Endosc 2001;15:715-9.
10. Tsioulias GJ, Wood TF, Spirt M, Morton DL, Bilchik AJ. A novel lymphatic mapping technique to improve localization and staging of early colon cancer during laparoscopic colectomy. Am Surg 2002;68:561-5.
11. Joosten JJ, Strobbe LJ, Wauters CA, Pruszczynski M, Wobbes T, Ruers TJ. Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg 1999;86:482-6.
12. Cserni G, Vajda K, Tarjan M, Bori R, Svebis M, Baltas B. Nodal staging of colorectal carcinomas from quantitative and qualitative aspects. Can lymphatic mapping help staging? Pathol Oncol Res 1999;5:291-6.
13. Wiese DA, Saha S, Badin J. Sentinel lymph node mapping in staging of colorectal carcinoma. Am J Clin Pathol 1999;112:542.
14. Saha S, Wiese D, Badin J, Beutler T, Nora D, Ganatra BK, et al. Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging. Ann Surg Oncol 2000;7:120-4.
15. Merrie AE, van Rij AM, Phillips LV, Rossaak JI, Yun K, Mccall JL. Diagnostic use of the sentinel node in colon cancer. Dis Colon Rectum 2001;44:410-7.
16. Evangelista W, Satolli MA, Malossi A, Mussa B, Sandrucci S. Sentinel lymph node mapping in colorectal cancer: A feasibility study. Tumori 2002;88:37-40.
17. Kitagawa Y, Fujii H, Mukai M, Kubota T, Ando N, Watanabe M, et al. The role of the sentinel lymph node in gastrointestinal cancer. Surg Clin North Am 2000;80:1799-809.
18. Kitagawa Y, Watanabe M, Hasegawa H, Yamamoto S, Fujii H, Yamamoto K, et al. Sentinel node mapping for colorectal cancer with radioactive tracer. Dis Colon Rectum 2002;45:1476-80.
19. Wong JH, Steineman S, Calderia C, Bowles J, Namiki T. Ex vivo sentinel node mapping in carcinoma of the colon and rectum. Ann Surg 2001;233:515-21.
20. Fitzgerald TL, Khalifa MA, Al Zahrani M, Law CH, Smith AJ. Ex vivo sentinel lymph node biopsy in colorectal cancer: A feasibility study. J Surg Oncol 2002;80:27-32.
21. Wood TF, Saha S, Morton DL, Tsioulias GJ, Rangel D, Hutchinson W Jr, et al. Validation of lymphatic mapping in colorectal cancer: In vivo, ex vivo, and laparoscopic techniques. Ann Surg Oncol 2001;8:150-7.
22. Saha S, Nora D, Wong JH, Weise D. Sentinel lymph node mapping in colorectal cancer - a review. Surg Clin North Am 2000;80:1811-9.
23. Bilchik AJ, Nora D, Tollenaar RA, van de Velde CJ, Wood T, Turner R, et al. Ultrastaging of early colon cancer using lymphatic mapping and molecular analysis. Eur J Cancer 2002;38:977-85.
24. Bertagnolli M, Miedema B, Redston M, Dowell J, Niedzwiecki D, Fleshman J, et al. Sentinel node staging of resectable colon cancer: Results of a multicenter study. Ann Surg 2004;240:624-8.
25. Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998;186:275-83.
26. Van Trappen PO, Pepper MS. Lymphatic dissemination of tumour cells and the formation of micrometastases. Lancet Oncol 2002;3:44-52.
27. Pantel K, Hosch SB. Molecular profiling of micrometastatic cancer cells. Ann Surg Oncol 2001;8:18S-21S.
28. Bukholm IR, Bondi J, Wiik P, Nesland JM, Andersen SN, Bakka A, et al. Presence of isolated tumour cells in mesenteric lymph nodes predicts poor prognosis in patients with stage II colon cancer. Eur J Surg Oncol 2003;29:862-6.
29. Esser S, Reilly WT, Riley LB, Eyvazzadeh C, Arcona S. The role of sentinel lymph node mapping in staging of colon and rectal cancer. Dis Colon Rectum 2001;44:850-4.
30. Feig BW, Curley S, Lucci A, Hunt KK, Vauthey JN, Mansfield PF, et al. A caution regarding lymphatic mapping in patients with colon cancer. Am J Surg 2001;182:707-12.
31. Saha S, Bilchik A, Wiese D, Espinosa M, Badin J, Ganatra BK, et al. Ultrastaging of colorectal cancer by sentinel lymph node mapping technique - a multicenter trial. Ann Surg Oncol 2001; 8(9 Suppl):94S-8S.
32. Paramo JC, Summerall J, Poppiti R, Mesko TW. Validation of sentinel node mapping in patients with colon cancer. Ann Surg Oncol 2002;9:550-4.
33. Bendavid Y, Latulippe JF, Younan RJ, Leclerc YE, Dube S, Heyen F, et al. Phase I study on sentinel lymph node mapping in colon cancer: A preliminary report. J Surg Oncol 2002;79:81-4.
34. Broderick-Villa G, Ko A, O'Connell TX, Guenther JM, Danial T, DiFronzo LA. Does tumor burden limit the accuracy of lymphatic mapping and sentinel lymph node biopsy in colorectal cancer? Cancer J 2002;8:445-50.
35. Trocha SD, Nora DT, Saha SS, Morton DL, Wiese D, Bilchik AJ. Combination probe and dye-directed lymphatic mapping detects micrometastases in early colorectal cancer. J Gastrointest Surg 2003; 7:340-5.
36. Bembenek A, Rau B, Moesta T, Markwardt J, Ulmer C, Gretschel S, et al. Sentinel lymph node biopsy in rectal cancer - not yet ready for routine clinical use. Surgery 2004;135:498-505.
37. Bertoglio S, Sandrucci S, Percivale P, Goss M, Gipponi M, Moresco L, et al. Prognostic value of sentinel lymph node biopsy in the pathologic staging of colorectal cancer patients. J Surg Oncol 2004;85:166-70.
38. Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW Jr. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 1994;73:563-9.
39. Jeffers MD, O'Dowd GM, Mulcahy H, Stagg M, O'Donoghue DP, Toner M. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol 1994;172:183-7.
40. Adell G, Boeryd B, Franlund B, Sjodahl R, Hakansson L. Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: An immunohistochemical study. Eur J Surg 1996;162:637-42.
41. Broll R, Schauer V, Schimmelpenning H, Strik M, Woltmann A, Best R, et al. Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas: An immunohistochemical study. Dis Colon Rectum 1997;40:1465-71.
42. Sasaki M, Watanabe H, Jass JR, Ajioka Y, Kobayashi M, Matsuda K, et al. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in "node-negative" colorectal cancer. J Gastroenterol 1997;32:758-64.
43. Liefers GJ, Cleton-Jansen AM, van de Velde CJ, Hermans J, van Krieken JH, Cornelisse CJ, et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998;339:223-8.
44. Mori M, Mimori K, Ueo H, Tsuji K, Shiraishi T, Barnard GF, et al. Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas. J Clin Oncol 1998; 16:128-32.
45. Oberg A, Stenling R, Tavelin B, Lindmark G. Are lymph node micrometastases of any clinical significance in Dukes stages A and B colorectal cancer? Dis Colon Rectum 1998;41:1244-9.
46. Cagir B, Gelmann A, Park J, Fava T, Tankelevitch A, Bittner EW, et al. Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer. Ann Intern Med 1999;131:805-12.
47. Nakanishi Y, Ochiai A, Yamauchi Y, Moriya Y, Yoshimura K, Hirohashi S. Clinical implications of lymph node micrometastases in patients with colorectal cancers. A case control study. Oncology 1999;57:276-80.
48. Clarke G, Ryan E, O'Keane JC, Crowe J, MacMathuna P. The detection of cytokeratins in lymph nodes of Duke's B colorectal cancer subjects predicts a poor outcome. Eur J Gastroenterol Hepatol 2000;12:549-52.
49. Rosenberg R, Hoos A, Mueller J, Baier P, Stricker D, Werner M, et al. Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients. J Clin Oncol 2002;20:1049-55.